Back to
Goldman Sachs Group Inc.
PROK
4 quarters
Position history for
Goldman Sachs Group Inc.'s holdings in ProKidney Corp.
Yes. Goldman Sachs holds 203,006 shares of PROK (ProKidney), worth $414,132, as of its Q2 2026 13F filing. It reduced the position by 218,896 shares (-51.9%) from Q1 2026. Goldman Sachs has held PROK in every 13F on record since Q3 2025, 4 quarterly filings.
Current Value
$414,132
Current Shares
203,006
Total Value Change
+$15,759
Total Shares Change
+38,389
Quarter-by-Quarter History
Other major holders of PROK: Morgan Stanley, BlackRock, Inc.